Cost drivers in the pharmacological treatment of interstitial lung disease

Abstract Introduction Treatments of interstitial lung diseases (ILDs) mainly focus on disease stabilization and relief of symptoms by managing inflammation or suppressing fibrosis by (in part costly) drugs. To highlight economic burden of drug treatment in different ILD-subtypes we assessed cost tre...

全面介绍

书目详细资料

Principais autores:	Phillen Nozibuyiso Maqhuzu, Michael Kreuter, Thomas Bahmer, Nicolas Kahn, Martin Claussen, Rolf Holle, Larissa Schwarzkopf
格式:	Artigo
语言:	Inglês
出版:	BMC 2021-08-01
丛编:	Respiratory Research
主题:	Diffuse parenchymal lung disease Healthcare expenditure Direct costs ILD management Healthcare spending
在线阅读:	https://doi.org/10.1186/s12931-021-01807-8
标签:	添加标签 没有标签, 成为第一个标记此记录!